Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 29,440
-585 (-1.95%)
Nov 27, 2025, 3:30 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 637.98 billion as of November 26, 2025. Its market cap has increased by 3.12% in one year.
Market Cap
637.98B
Enterprise Value
616.38B
Revenue
67.14B
Ranking
n/a
PE Ratio
42.28
Stock Price
29,440.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 637.98B, an increase of 13,276.85%. That is a compound annual growth rate of 22.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 637.98B | 0.93% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | 334.90B | 20.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.73T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 934.29B |
| Mankind Pharma | 932.38B |
| Aurobindo Pharma | 712.88B |
| Fortis Healthcare | 694.86B |